Get the Stockscreener App
22.83
4.06%
-0.965
After Hours:
22.81
-0.02
-0.09%
Sionna Therapeutics Inc stock is traded at $22.83, with a volume of 171.44K.
It is down -4.06% in the last 24 hours and up +8.77% over the past month.
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.
See More
Previous Close:
$23.80
Open:
$23.79
24h Volume:
171.44K
Relative Volume:
0.80
Market Cap:
$1.01B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-4.88%
1M Performance:
+8.77%
6M Performance:
+33.43%
1Y Performance:
+0.00%
1-Day Range:
$22.56
$24.31
1-Week Range:
$20.60
$26.47
52-Week Range:
$7.255
$26.50
Sionna Therapeutics Inc Stock (SION) Company Profile
Name
Sionna Therapeutics Inc
Sector
Industry
Phone
617-819-2020
Address
21 HICKORY DRIVE, SUITE 500, WALTHAM
Compare SION with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SION
Sionna Therapeutics Inc
|
22.83 | 1.04B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Sionna Therapeutics Inc Stock (SION) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Initiated | RBC Capital Mkts | Sector Perform |
| Sep-03-25 | Initiated | Raymond James | Strong Buy |
| Mar-04-25 | Initiated | Guggenheim | Buy |
| Mar-04-25 | Initiated | Stifel | Buy |
| Mar-04-25 | Initiated | TD Cowen | Buy |
Sionna Therapeutics Inc Stock (SION) Latest News
Sionna Therapeutics (NASDAQ:SION) Now Covered by Jones Trading - MarketBeat
Candlestick signals on Sionna Therapeutics Inc. stock today2025 Year in Review & Momentum Based Trading Ideas - Newser
Is it time to cut losses on Sionna Therapeutics Inc.July 2025 Opening Moves & Fast Entry and Exit Trade Plans - Newser
Using data models to predict Sionna Therapeutics Inc. stock movementJuly 2025 Short Interest & AI Optimized Trade Strategies - Newser
Can you recover from losses in Sionna Therapeutics Inc.Earnings Risk Report & AI Powered Trade Plan Recommendations - Newser
Chart based analysis of Sionna Therapeutics Inc. trends2025 Top Decliners & Entry Point Confirmation Alerts - Newser
What the charts say about Sionna Therapeutics Inc. todayWeekly Trade Recap & Weekly Hot Stock Watchlists - Newser
Real time scanner hits for Sionna Therapeutics Inc. explainedRecession Risk & Verified Momentum Watchlists - Newser
Best data tools to analyze Sionna Therapeutics Inc. stockJuly 2025 Short Interest & Weekly Breakout Opportunity Watchlist - Newser
How to read the order book for Sionna Therapeutics Inc.2025 Top Decliners & Fast Gain Swing Trade Alerts - Newser
186,222 Shares in Sionna Therapeutics, Inc. $SION Purchased by Alyeska Investment Group L.P. - MarketBeat
Using Ichimoku Cloud for Sionna Therapeutics Inc. technicalsWeekly Gains Summary & Smart Investment Allocation Tips - Newser
Visual analytics tools that track Sionna Therapeutics Inc. performanceJuly 2025 Recap & Verified Chart Pattern Trade Signals - Newser
Is Sionna Therapeutics Inc. stock ready for a breakout2025 EndofYear Setup & Safe Capital Allocation Plans - Newser
Sionna Therapeutics Inc. stock prediction for this weekEarnings Summary Report & Safe Capital Growth Trade Ideas - Newser
How to track smart money flows in Sionna Therapeutics Inc.CEO Change & Momentum Based Trading Signals - Newser
Should you hold or exit Sionna Therapeutics Inc. nowTreasury Yields & Stepwise Trade Signal Guides - Newser
Sionna Therapeutics (NASDAQ:SION) Shares Up 6.3%Still a Buy? - MarketBeat
Zimmer Partners LP Takes Position in Sionna Therapeutics, Inc. $SION - MarketBeat
Published on: 2025-09-10 23:41:49 - Newser
Why Sionna Therapeutics Inc. stock attracts strong analyst attentionMarket Risk Report & Reliable Entry Point Trade Alerts - Newser
Tick level data insight on Sionna Therapeutics Inc. volatilityWeekly Stock Summary & Expert Curated Trade Setup Alerts - Newser
How to build a custom watchlist for Sionna Therapeutics Inc.2025 Investor Takeaways & Growth Focused Stock Pick Reports - Newser
Sionna Short Squeeze Fades As Raymond James Backs Cystic Fibrosis Breakthrough, RBC Warns Treatments Set High Bar - Stocktwits
Patients the ‘North Star’ for Sionna-bound Caroline Stark Beer - The Pharma Letter
Sionna Therapeutics Inc. stock outlook for YEAR2025 Price Momentum & Free Growth Oriented Trading Recommendations - Newser
Using data filters to optimize entry into Sionna Therapeutics Inc.Market Trend Report & Reliable Intraday Trade Alerts - Newser
Trend analysis for Sionna Therapeutics Inc. this weekQuarterly Trade Review & Safe Entry Point Identification - Newser
Will earnings trigger a reversal in Sionna Therapeutics Inc.Share Buyback & Verified Momentum Stock Watchlist - Newser
Will Sionna Therapeutics Inc. price bounce be sustainableWeekly Profit Report & Proven Capital Preservation Methods - Newser
Full technical analysis of Sionna Therapeutics Inc. stockJuly 2025 Closing Moves & Stepwise Entry/Exit Trade Alerts - Newser
How moving averages guide Sionna Therapeutics Inc. tradingPortfolio Gains Summary & Fast Exit Strategy with Risk Control - Newser
Has Sionna Therapeutics Inc. found a price floorMarket Trend Summary & Entry Point Confirmation Alerts - Newser
Sionna Therapeutics Inc Stock (SION) Financials Data
There is no financial data for Sionna Therapeutics Inc (SION). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):